Recombinant attenuated M.tuberculosis-SIVgag(rAMtb-gag) vaccination primes for SIV-specific CD8 T cell response that are boosted by Ad5-SIVgag in mice by Kadayam Ranganathan U, Larsen M, Abel K, Jacobs WR, Fennelly G

Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents. by Sharp, E, Willberg, C, Kuebler, P, Abadi, J, Fennelly, G, Dobroszycki, J, Wiznia, A, Rosenberg, MG, Nixon, D

Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children. by Sharp, E, Willberg, C, Kuebler, P, Abadi, J, Fennelly, G, Dobroszycki, J, Wiznia, A, Rosenberg, MG, Nixon, D

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques by Jensen K, Ranganathan UD, Kozlowski P, Van Rompay K, Canfield D, Ravindran R, Khan I, Luciw P, Fennelly G, Larsen M, Abel K

The pathogenetic aspects of measles virus infection: memorandum from a WHO meeting. by Billeter, M, Bellini, W, Vanbinnendijk, R, Borrow, P, Brown, F, Cutts, F, Fennelly, G, Gellin, B, Griffin, D, Katz, S, Kolakofsky, D, Kreth, H, Liebert, U, Leopardi, R, Mcintosh, K, Termeulen, V, Minor, P, Moyer, S, Murphy, B, Naniche, D, Norrby, E, Ogra, P, Osterhaus, A, Paoletti, E, Rima, B